Amyris Inc (AMRS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH18240D
- Pages: 33
- October 2018
- Total Views:1231
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
Amyris Inc (Amyris), formerly Amyris Biotechnologies Inc is a healthcare product manufacturer that offers integrated renewable products. The company provides sustainable alternatives to a range of petroleum-sourced products and rare materials. It offers health and wellness products, clean beauty products, and flavour and fragrance products. Amyris's health and wellness products include artemisinin-based combination therapies (ACT's), nutraceuticals and natural sweeteners. The company's clean beauty products comprise cosmetic ingredients and biossance. It offers plant-sugars for anti-malarial drugs. The company has operational presence in the US, Brazil, and the Netherlands. Amyris is headquartered in Emeryville, California, the US.
Amyris Inc (AMRS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amyris Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amyris Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amyris Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Amyris to Form Joint Venture with BGI Genomics 10
Amyris Enters into Agreement with Biogen 11
Amyris Enters into Research Agreement with Janssen Biotech 12
Amyris to Enter into Co-Development Agreement with Ipca Labs 13
Equity Offering 14
Amyris Raises USD47.8 Million in Public Offering of Shares 14
Amyris Raises USD50 Million in Second and Final Tranche of Private Placement of Shares 15
Amyris Raises USD47 Million in First Tranche of Private Placement of Shares 17
Amyris Raises USD25 Million in Private Placement of Shares 19
Amyris Completes Private Placement Of Shares For USD 5 Million 20
Amyris Completes Private Placement Of Shares For USD 37 Million 21
Amyris Completes Private Placement Of Common Stock For USD 58.7 Million 22
Debt Offering 23
Amyris Prices Private Placement of 9.5% Notes Due 2019 for USD57.6 Million 23
Amyris Completes Private Placement Of Notes Due 2017 For Additional USD 20 Million 24
Amyris Completes Private Placement Of 1.5% Senior Notes Due 2017 For USD 20 Million 25
Amyris Completes Private Placement Of 1.5% Senior Notes Due 2017 For USD 10 Million 26
Amyris Completes Private Placement Of 3% Senior Unsecured Notes For USD 25 Million 27
Acquisition 28
Royal DSM Acquires Amyris Brasil 28
Amyris Inc-Key Competitors 29
Amyris Inc-Key Employees 30
Amyris Inc-Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Recent Developments 32
Government and Public Interest 32
Jan 17, 2018: Amyris Announces Over USD 25 Million in Grants 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List Of Figure
List of Figures
Amyris Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amyris Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Amyris Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amyris Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amyris Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Amyris Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amyris to Form Joint Venture with BGI Genomics 10
Amyris Enters into Agreement with Biogen 11
Amyris Enters into Research Agreement with Janssen Biotech 12
Amyris to Enter into Co-Development Agreement with Ipca Labs 13
Amyris Raises USD47.8 Million in Public Offering of Shares 14
Amyris Raises USD50 Million in Second and Final Tranche of Private Placement of Shares 15
Amyris Raises USD47 Million in First Tranche of Private Placement of Shares 17
Amyris Raises USD25 Million in Private Placement of Shares 19
Amyris Completes Private Placement Of Shares For USD 5 Million 20
Amyris Completes Private Placement Of Shares For USD 37 Million 21
Amyris Completes Private Placement Of Common Stock For USD 58.7 Million 22
Amyris Prices Private Placement of 9.5% Notes Due 2019 for USD57.6 Million 23
Amyris Completes Private Placement Of Notes Due 2017 For Additional USD 20 Million 24
Amyris Completes Private Placement Of 1.5% Senior Notes Due 2017 For USD 20 Million 25
Amyris Completes Private Placement Of 1.5% Senior Notes Due 2017 For USD 10 Million 26
Amyris Completes Private Placement Of 3% Senior Unsecured Notes For USD 25 Million 27
Royal DSM Acquires Amyris Brasil 28
Amyris Inc, Key Competitors 29
Amyris Inc, Key Employees 30
Amyris Inc, Subsidiaries 31
Amyris Inc, Joint Venture 31
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Amyris Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Amyris Inc (Amyris), formerly Amyris Biotechnologies Inc is a healthcare product manufacturer that offers integrated renewable products. The company provides sustainable alternatives to a range of petroleum-sourced products and rare materials. It offers health and wellness products, clean beauty products, and flavour and fragrance products. Amyris's health and wellness products include artemisinin-based combination therapies (ACT's), nutraceuticals and natural sweeteners. The company's clean beauty products comprise cosmetic ingredients and biossance. It offers plant-sugars for anti-malarial drugs. The company has operational presence in the US, Brazil, and the Netherlands. Amyris is headquartered in Emeryville, California, the US.
Amyris Inc (AMRS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amyris Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Amyris Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amyris Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Amyris to Form Joint Venture with BGI Genomics 10
Amyris Enters into Agreement with Biogen 11
Amyris Enters into Research Agreement with Janssen Biotech 12
Amyris to Enter into Co-Development Agreement with Ipca Labs 13
Equity Offering 14
Amyris Raises USD47.8 Million in Public Offering of Shares 14
Amyris Raises USD50 Million in Second and Final Tranche of Private Placement of Shares 15
Amyris Raises USD47 Million in First Tranche of Private Placement of Shares 17
Amyris Raises USD25 Million in Private Placement of Shares 19
Amyris Completes Private Placement Of Shares For USD 5 Million 20
Amyris Completes Private Placement Of Shares For USD 37 Million 21
Amyris Completes Private Placement Of Common Stock For USD 58.7 Million 22
Debt Offering 23
Amyris Prices Private Placement of 9.5% Notes Due 2019 for USD57.6 Million 23
Amyris Completes Private Placement Of Notes Due 2017 For Additional USD 20 Million 24
Amyris Completes Private Placement Of 1.5% Senior Notes Due 2017 For USD 20 Million 25
Amyris Completes Private Placement Of 1.5% Senior Notes Due 2017 For USD 10 Million 26
Amyris Completes Private Placement Of 3% Senior Unsecured Notes For USD 25 Million 27
Acquisition 28
Royal DSM Acquires Amyris Brasil 28
Amyris Inc-Key Competitors 29
Amyris Inc-Key Employees 30
Amyris Inc-Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Recent Developments 32
Government and Public Interest 32
Jan 17, 2018: Amyris Announces Over USD 25 Million in Grants 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List Of Figure
List of Figures
Amyris Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amyris Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Amyris Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Amyris Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Amyris Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Amyris Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Amyris Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Amyris to Form Joint Venture with BGI Genomics 10
Amyris Enters into Agreement with Biogen 11
Amyris Enters into Research Agreement with Janssen Biotech 12
Amyris to Enter into Co-Development Agreement with Ipca Labs 13
Amyris Raises USD47.8 Million in Public Offering of Shares 14
Amyris Raises USD50 Million in Second and Final Tranche of Private Placement of Shares 15
Amyris Raises USD47 Million in First Tranche of Private Placement of Shares 17
Amyris Raises USD25 Million in Private Placement of Shares 19
Amyris Completes Private Placement Of Shares For USD 5 Million 20
Amyris Completes Private Placement Of Shares For USD 37 Million 21
Amyris Completes Private Placement Of Common Stock For USD 58.7 Million 22
Amyris Prices Private Placement of 9.5% Notes Due 2019 for USD57.6 Million 23
Amyris Completes Private Placement Of Notes Due 2017 For Additional USD 20 Million 24
Amyris Completes Private Placement Of 1.5% Senior Notes Due 2017 For USD 20 Million 25
Amyris Completes Private Placement Of 1.5% Senior Notes Due 2017 For USD 10 Million 26
Amyris Completes Private Placement Of 3% Senior Unsecured Notes For USD 25 Million 27
Royal DSM Acquires Amyris Brasil 28
Amyris Inc, Key Competitors 29
Amyris Inc, Key Employees 30
Amyris Inc, Subsidiaries 31
Amyris Inc, Joint Venture 31
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Amyris Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
: +91 9654982241
Related Reports
Page 140 | 
September 2022
Page 85 | September 2022
Page 90 | August 2022
Page 89 | August 2022
Page 130 | July 2022